U.S. Online Retail and Ecommerce Stock News

If you are wondering whether Sarepta Therapeutics at US$20.80 is starting to look like value or still carries too much risk, the recent share price and fundamentals give you a lot to weigh up. The stock has been under pressure, with returns of 0.4% decline over 7 days, 9.9% decline over 30 days, 2.4% decline year to date, 43.0% decline over 1 year and 82.7% decline over 3 years, while the 5 year return sits at 71.3% decline. Recent news around Sarepta Therapeutics has focused on its position...

National Health Investors (NYSE:NHI) is selling its entire skilled nursing facility portfolio for $560 million. The company plans to redeploy proceeds into private-pay senior housing, including a seven-property portfolio in Colorado. This shift reduces exposure to skilled nursing and increases focus on private-pay assets that management views as offering more attractive risk adjusted returns. For investors watching NYSE:NHI, this move comes with the stock recently closing at $75.07 and...

Organogenesis Holdings (ORGO) closed FY 2025 with fourth quarter revenue of US$225.6 million and basic EPS of US$0.28, alongside net income of US$35.1 million that capped a profitable trailing twelve month period. The company has seen quarterly revenue move from US$126.7 million and EPS of US$0.05 in Q4 2024 to US$225.6 million and EPS of US$0.28 in Q4 2025. Trailing twelve month EPS shifted from roughly flat at US$0.01 in Q4 2024 to US$0.16 in Q4 2025, setting up a results season where the...

Pacific Biosciences of California (PACB) has just posted its FY 2025 numbers, with Q4 revenue at US$44.6 million and a basic EPS loss of US$0.13 set against trailing twelve month revenue of US$160.0 million and a TTM basic EPS loss of US$1.82. Over the past six reported quarters, the company has seen quarterly revenue move between US$37.2 million and US$44.6 million, while basic EPS has ranged from a small profit of US$0.01 in FY 2024 Q4 to a loss of US$1.44 in FY 2025 Q1. This leaves...

Genius Sports (GENI) opened Q1 2026 with revenue of US$188 million, a basic EPS loss of US$0.21 per share, and net income loss of US$55 million, setting a cautious tone around near term profitability. The company has seen quarterly revenue move from US$144 million in Q1 2025 to US$188 million in Q1 2026, while basic EPS shifted from a loss of US$0.03 to a loss of US$0.21 over the same period. This puts the focus squarely on how efficiently that extra revenue is translating into results. For...

Why National Storage Affiliates Trust is on investors’ radar National Storage Affiliates Trust (NSA) has drawn attention after its recent share performance, with the stock showing positive returns over the past week, month and past 3 months. This has invited closer inspection from income focused REIT investors. See our latest analysis for National Storage Affiliates Trust. While the 1 day share price return was slightly negative, the recent 30 day and year to date share price returns of...

In early May 2026, NIKE, Inc.’s board declared a quarterly cash dividend of US$0.41 per share on its Class A and Class B common stock, payable on July 1, 2026, to shareholders of record as of June 1, 2026. The dividend decision comes as Nike faces analyst downgrades, business headwinds, and legal and regulatory scrutiny that are testing confidence in its turnaround plan. Next, we’ll examine how Wells Fargo’s downgrade, tied to weaker athletic footwear demand and global challenges, reshapes...

ACADIA Pharmaceuticals (ACAD) opened 2026 with Q1 revenue of $268.1 million and basic EPS of $0.02, against a backdrop of trailing twelve month revenue of $1.1 billion, basic EPS of $2.22 and net income of $375.7 million. Over recent quarters, the company has seen revenue move from $244.3 million in Q1 2025 to $268.1 million in Q1 2026, while quarterly basic EPS has ranged from $0.11 to $1.62. These results come within a period of margin expansion and earnings growth that investors now need...

If you are wondering whether Ouster's share price still offers value after a strong run, it helps to start by lining up the recent returns with what the current valuation really implies. Ouster's stock closed at US$24.51, with returns of 26.8% over 30 days, 4.9% year to date and 183.4% over 1 year, while the last 7 days show a 9.1% decline and the 5 year figure sits at a 70.9% loss. Taken together, these figures suggest investors have been reassessing both potential and risk over different...

Why SharkNinja Is Drawing Investor Attention Now SharkNinja (SN) is back on investor radars after a recent stretch of mixed returns, with the stock down over the past week but positive over the month and the past year. This mixed price pattern, together with the company’s current market value of about US$16.35b and reported revenue of US$6.59b with net income of US$705.00m, is prompting a closer look at how the stock is currently valued. See our latest analysis for SharkNinja. At a share...

Why Evercore’s latest quarter caught investor attention Evercore (EVR) just reported first quarter results showing revenue of US$1,400.47 million and net income of US$301.24 million, alongside an active buyback program and a higher quarterly dividend to shareholders. See our latest analysis for Evercore. At a share price of US$331.28, Evercore’s stock has had a 7.94% 1 month share price return. The 1 year total shareholder return of 54.60% contrasts with weaker performance over the past...

In early May 2026, Erie Indemnity reported first-quarter results that fell short of analyst expectations on both earnings per share and revenue, coinciding with its shares touching a fresh 52-week low. Despite this disappointment and a roughly US$2.30 billions reduction in market value over a recent losing streak, a premarket rebound suggested some investors still saw positives in the company’s underlying performance. With recent earnings missing forecasts and raising questions about...

This article considers whether Coinbase Global's recent share price suggests a potential bargain or already reflects its current story, by comparing its value against several common yardsticks. At a last close of US$192.96, the stock has returned 2.8% over the past week and 10.1% over the past month. It is down 18.4% year to date and has returned 219.7% over three years and 27.2% over five years. Recent headlines around Coinbase Global have focused on its role as a listed gateway to crypto...

In early May 2026, V2X, Inc. completed a US$149.04 million follow-on common stock offering at US$74.35 per share, shortly after reporting first-quarter sales of US$1,254.13 million and net income of US$18.93 million, and increasing its full-year 2026 revenue guidance to a range of US$4.83 billion to US$4.98 billion. The company’s roughly US$4.10 billion in new awards and record US$13.80 billion backlog highlight how recent contract wins are shaping management’s more confident outlook and...

Applied Digital recently completed the spin-off of its cloud business into ChronoScale, a new Nasdaq-listed company in which it retains about 97% ownership, and closed a US$300 million senior secured bridge facility led by Goldman Sachs to fund construction of its third AI data center at the Polaris Forge 1 campus in North Dakota. This combination of corporate restructuring and fresh project financing reshapes how investors can assess Applied Digital’s capital needs, risk profile, and...

CrowdStrike Holdings (CRWD) has been in focus after rolling out a series of AI centered upgrades, from integrating Anthropic’s Claude Opus 4.7 via Project QuiltWorks to launching Falcon OverWatch for Defender and the Jet mobile app. See our latest analysis for CrowdStrike Holdings. The recent AI focused launches and partner updates come alongside strong momentum in the stock, with a 27.87% 90 day share price return and a very large 3 year total shareholder return. This signals that investors...

Warner Music Group and Paramount Pictures have agreed a multi year, first look partnership to develop theatrical films based on Warner Music artists and songwriters. The deal focuses on creating new cinema projects that tap into both legendary and contemporary acts from Warner Music Group. This collaboration pairs a major recorded music company with a leading Hollywood studio to build film concepts around music IP. For investors watching NasdaqGS:WMG, this new film partnership sits...

If you are wondering whether Regeneron Pharmaceuticals at around US$709.10 is priced attractively or already reflects the story, the valuation picture is where the answers start to emerge. The stock is up 0.3% over the last 7 days, while it shows a 6.7% decline over 30 days, an 8.7% decline year to date, and a 30.2% return over the past year, which can change how investors think about both upside potential and risk. Recent headlines around Regeneron often focus on its position within large...

Atlassian (NasdaqGS:TEAM) has launched major AI native platform upgrades, highlighted by the open Teamwork Graph and new autonomous agent capabilities. The new features, including agents in Rovo and Jira, are designed to help teams plan, execute, and automate work across Atlassian and third party tools. Governance and security controls are built into the platform, targeting enterprise use cases where data access and compliance are critical. Atlassian is best known for tools like Jira and...

Tower Semiconductor (NasdaqGS:TSEM) is back in focus after S&P’s Maalot unit shifted its credit rating outlook to Positive and Axiro’s radar chips on Tower’s SiGe process began ramping into volume production for U.S. defense systems. See our latest analysis for Tower Semiconductor. The latest credit outlook shift and defense ramp-up come after a very strong run, with a 51.0% 90-day share price return and a year-to-date share price return of 72.5%, alongside a very large 1-year total...

LyondellBasell Industries N.V. has released its first-quarter 2026 results, reporting revenue of US$7,197 million and net income of US$123 million, with adjusted earnings per share from continuing operations of US$0.49 coming in ahead of analyst expectations. Management highlighted that tighter global petrochemical supply linked to Middle East disruptions, combined with operational discipline and increased production, is supporting stronger pricing and an expected sequential improvement in...

L3Harris Technologies recently reported first-quarter 2026 results showing sales of US$5,744 million and net income of US$512 million, while also modestly raising its full-year 2026 revenue and diluted EPS guidance. The combination of higher quarterly earnings per share and tighter, upgraded EPS guidance highlights management’s confidence in the company’s operating performance and outlook. Next, we’ll explore how this upgraded 2026 earnings guidance may affect L3Harris’s existing investment...

Agilysys, Inc. recently unveiled more than 30 new AI-powered features and software modules at its April 20–23, 2026 INSPIRE user conference, many of which are in early release and slated for initial customer deployments within about 90 days, while also announcing plans to release its fiscal 2026 fourth-quarter results on May 18, 2026. The breadth of these AI-native enhancements, spanning guest personalization, agentic automation, and revenue intelligence across its PMS, POS, and reservations...

Wondering if Donnelley Financial Solutions at around US$44 is offering value or just noise? This article breaks down what the current price might actually mean for you. The stock recently closed at US$44.21, with returns of a 12.1% decline over 7 days, a 10.0% decline over 30 days and a 3.1% decline year to date, alongside a 17.2% decline over 1 year, a 0.2% decline over 3 years and a 73.6% gain over 5 years. Recent coverage of Donnelley Financial Solutions has focused on its role in...